United Therapeutics Corporation
Martine A Rothblatt (Chairperson & CEO) sells UTHR shares
AI-generated summary
Chairperson & CEO, Director Martine A Rothblatt exercised 9,500 stock options for 9,500 shares of Common Stock valued at $1,118,720 and subsequently sold 9,500 shares of Common Stock for $5,583,500.99. Following these transactions, the insider indirectly holds 324,443 shares of Common Stock through a trust. The transactions were executed under a Rule 10b5-1 trading plan adopted on November 7, 2025.
Key facts
- Insider
- Martine A Rothblatt · Chairperson & CEO, Director
Rule 10b5-1 plan · adopted Nov 7, 2025
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +9,500 | $117.76 | $1,118,720.00 | 333,943 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F3, F2 | −110 | $580.25 | $63,827.82 | 333,833 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F4, F2 | −170 | $581.25 | $98,812.69 | 333,663 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F5, F2 | −280 | $582.18 | $163,010.37 | 333,383 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F6, F2 | −240 | $583.61 | $140,066.02 | 333,143 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F7, F2 | −640 | $584.54 | $374,103.94 | 332,503 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F8, F2 | −1,382 | $585.83 | $809,620.65 | 331,121 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F9, F2 | −2,108 | $586.72 | $1,236,796.06 | 329,013 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F10, F2 | −1,090 | $587.61 | $640,491.96 | 327,923 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F11, F2 | −835 | $588.59 | $491,474.99 | 327,088 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F12, F2 | −575 | $590.25 | $339,391.39 | 326,513 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F13, F2 | −996 | $591.26 | $588,891.47 | 325,517 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F14, F2 | −514 | $592.05 | $304,312.16 | 325,003 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F15, F2 | −240 | $593.16 | $142,357.87 | 324,763 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F16, F2 | −200 | $594.60 | $118,920.80 | 324,563 | Indirect (by Trust) |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F2 | −120 | $595.19 | $71,422.80 | 324,443 | Indirect (by Trust) |
| Nov 16, 2026 | M · exercise or conversion of a derivativeStock OptionFootnotes F1, F20, F21 | −9,500 | $0.00 | $0.00 | 14,910 | Indirect (by Trust) |
Footnotes
- F1 This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10 This transaction was executed in multiple trades at prices ranging from $587.24 to $587.985. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11 This transaction was executed in multiple trades at prices ranging from $588.24 to $589.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12 This transaction was executed in multiple trades at prices ranging from $589.63 to $590.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13 This transaction was executed in multiple trades at prices ranging from $590.63 to $591.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14 This transaction was executed in multiple trades at prices ranging from $591.63 to $592.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15 This transaction was executed in multiple trades at prices ranging from $592.99 to $593.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16 This transaction was executed in multiple trades at prices ranging from $594.08 to $595.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F17 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F18 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F19 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F2 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F20 These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F21 Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F3 This transaction was executed in multiple trades at prices ranging from $579.65 to $580.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4 This transaction was executed in multiple trades at prices ranging from $580.72 to $581.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5 This transaction was executed in multiple trades at prices ranging from $581.74 to $582.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6 This transaction was executed in multiple trades at prices ranging from $583.02 to $583.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7 This transaction was executed in multiple trades at prices ranging from $584.08 to $584.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8 This transaction was executed in multiple trades at prices ranging from $585.22 to $586.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9 This transaction was executed in multiple trades at prices ranging from $586.22 to $587.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More UTHR filings
- 4
Filed Nov 19, 2026
- 4
Filed Nov 19, 2026
- 144
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 16, 2026
- 4
Filed Nov 13, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.